Worldwide Life Sciences R&D AI in Clinical Trials Assessment

This document is an IDC MarketScape vendor assessment focused on the application of AI, including GenAI, in clinical trials within the life sciences sector for the year 2025. It outlines the evolving landscape where AI has become a pivotal element in the strategies of pharmaceutical companies. The assessment highlights the critical factors for successful AI implementation, such as enterprise data readiness, use case prioritization, and change management strategies. It also discusses the challenges faced by technology vendors and the life sciences industry in adopting AI solutions, including issues related to data integration, regulatory compliance, and workforce concerns. Furthermore, the document emphasizes the importance of collaboration across functions and the need for a strategic approach to AI investments that align with business objectives. Metrics for measuring the success of AI initiatives are also presented, focusing on productivity gains and improved clinical outcomes. The document serves as a guide for technology buyers in the life sciences sector to navigate the complexities of AI adoption.